Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry

Recruitment-status index

TerminatedPeptide Trials.

Explore every peptide study grouped under terminated in the local registry snapshot. Check the source record before relying on recruitment status, because registry entries can change.

Studies
159
Recruiting
0
Completed
0
Results posted
83
Countries
53
Avg enrollment
146

Velocity

Terminated trials by start year

Study start year · indexed snapshot

161284020022002: 2 trials2003: 0 trials2004: 3 trials2005: 1 trials20062006: 5 trials2007: 8 trials2008: 5 trials2009: 7 trials20102010: 3 trials2011: 10 trials2012: 11 trials2013: 9 trials20142014: 6 trials2015: 12 trials2016: 13 trials2017: 9 trials20182018: 16 trials2019: 7 trials2020: 6 trials2021: 7 trials20222022: 11 trials2023: 4 trials2024: 1 trials20252025: 3 trials

Development

Trials by phase

Early Phase 11
Phase 122
Phase 251
Phase 332
Phase 435

Industry

Leading sponsors

Ipsen8
Sanofi6
Allergan5
AstraZeneca4
GlaxoSmithKline4
Novartis4
Stealth BioTherapeutics Inc.3
Theratechnologies3

Therapeutic areas

Condition groups

Type 2 diabetes15
Weight loss7
Pain6
Longevity3
Brain health2
Inflammation1
Muscle growth1

Compound leaders

Most represented peptides.

01Lanreotide1302Pasireotide1003Bivalirudin804Calcitonin605Desmopressin606Enfuvirtide607Eptifibatide608Lixisenatide609Relamorelin610Secretin611Exenatide512Nesiritide5

Study explorer

Search this collection.

159 matching studies